Deutsche Bank made positive comments on Buy-rated Chelsea Therapeutics (NASDAQ: CHTP) following interim results, which has the stock down ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE